Business Description
Zhejiang Garden Biopharmaceutical Co Ltd
ISIN : CNE100001XX7
Share Class Description:
SZSE:300401: Class ACompare
Compare
Traded in other countries / regions
300401.China IPO Date
2014-10-09Description
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.8 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 6.96 | |||||
| Interest Coverage | 6.53 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.97 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.8 | |||||
| 3-Year EBITDA Growth Rate | -1.9 | |||||
| 3-Year EPS without NRI Growth Rate | -28.7 | |||||
| 3-Year FCF Growth Rate | 24.6 | |||||
| 3-Year Book Growth Rate | 0.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 58.99 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 32.64 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.81 | |||||
| 9-Day RSI | 84.76 | |||||
| 14-Day RSI | 74.4 | |||||
| 6-1 Month Momentum % | 36.42 | |||||
| 12-1 Month Momentum % | 16.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.79 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 1.1 | |||||
| Days Inventory | 606.37 | |||||
| Days Sales Outstanding | 48.32 | |||||
| Days Payable | 274.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.45 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| Forward Dividend Yield % | 0.45 | |||||
| 5-Year Yield-on-Cost % | 0.45 | |||||
| Shareholder Yield % | -7.9 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.01 | |||||
| Operating Margin % | 21.65 | |||||
| Net Margin % | 20.93 | |||||
| FCF Margin % | -13.61 | |||||
| ROE % | 7.33 | |||||
| ROA % | 3.98 | |||||
| ROIC % | 5.32 | |||||
| 3-Year ROIIC % | -3.77 | |||||
| ROC (Joel Greenblatt) % | 9.55 | |||||
| ROCE % | 6.88 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.12 | |||||
| Forward PE Ratio | 19.41 | |||||
| PE Ratio without NRI | 53.52 | |||||
| Shiller PE Ratio | 33.36 | |||||
| PS Ratio | 9.3 | |||||
| PB Ratio | 2.81 | |||||
| Price-to-Tangible-Book | 3.02 | |||||
| Price-to-Operating-Cash-Flow | 49.61 | |||||
| EV-to-EBIT | 28.12 | |||||
| EV-to-EBITDA | 28.12 | |||||
| EV-to-Revenue | 7.51 | |||||
| EV-to-FCF | -55.2 | |||||
| Price-to-Projected-FCF | 7.03 | |||||
| Price-to-Median-PS-Value | 0.89 | |||||
| Price-to-Graham-Number | 2.68 | |||||
| Price-to-Net-Current-Asset-Value | 98 | |||||
| Earnings Yield (Greenblatt) % | 3.56 | |||||
| FCF Yield % | -1.66 | |||||
| Forward Rate of Return (Yacktman) % | -12.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Garden Biopharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,038.08 | ||
| EPS (TTM) (Â¥) | 0.34 | ||
| Beta | 1.17 | ||
| Volatility % | 48.08 | ||
| 14-Day RSI | 74.4 | ||
| 14-Day ATR (Â¥) | 0.672025 | ||
| 20-Day SMA (Â¥) | 12.708 | ||
| 12-1 Month Momentum % | 16.01 | ||
| 52-Week Range (Â¥) | 7.58 - 18.18 | ||
| Shares Outstanding (Mil) | 541.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Garden Biopharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Garden Biopharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Garden Biopharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401)'s stock price today?
The current price of SZSE:300401 is ¥15.68. The 52 week high of SZSE:300401 is ¥18.18 and 52 week low is ¥7.58.
When is next earnings date of Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401)?
The next earnings date of Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401) is .
Does Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401) is 0.45% (As of Today), Highest Dividend Payout Ratio of Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401) was 0.83. The lowest was 0.07. And the median was 0.2. The  Forward Dividend Yield % of Zhejiang Garden Biopharmaceutical Co Ltd(SZSE:300401) is 0.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers